{"title_page": "Polypure", "text_new": "{{Infobox company\n | name             = Polypure AS.\n | logo             = Polypure logo.svg\n | type             = [[Private company|Privately held]] \n | genre            = \n | foundation       = 1999\n | founder          = \n | location_city    = [[Oslo]]\n | location_country = [[Norway]]\n | location         = \n | locations        = \n | area_served      = Global\n | key_people       = [[Erik Agner]]<small> ([[Chief Executive Officer|CEO]])</small>\n | industry         = [[Pharmaceutical]]\n | products         =  [[Fine chemicals]]\n | services         = \n | revenue          = \n | operating_income = \n | net_income       = \n | owner            = \n | num_employees    = \n | parent           = \n | divisions        = \n | subsid           = \n | slogan           = \n | homepage         = [http://www.polypure.no polypure.no]\n | footnotes        = \n | intl             =\n}}\n\n'''Polypure''' is a [[Norway|Norwegian]] company that manufactures and markets monodisperse PEG (poly[[ethylene glycol]]) derivatives for applications in [[nanotechnology]], [[biotechnology]] and in [[pharmaceutical sciences]]. \n\nIts headquarters are located in the [[Oslo Innovation Center]],<ref>[http://www.forskningsparken.no/ Hovedside - Forskningsparken<!-- Bot generated title -->]</ref> [[Oslo]], [[Norway]]. The company has been in operation since 1999.\n\nThe compounds are produced using a proprietary purification technology called Sample [[Displacement Chromatography]] (SDC).<ref>US Patent number: 6245238</ref> The technique exploits the [[correlation]] between [[molecular weight]] and binding strength of PEG species. That is, individual PEG molecules bind to the matrix within a [[chromatography]] column at differing [[Chemical affinity|affinity]] depending on their molecular weight. Because of this property, when PEG is applied to the top of a chromatography column, strong binding species take possession of the first binding positions available and thereby force weaker binders to follow the liquid flow down the column to the next vacant positions. This results in the spatial separation of PEG species within the column according to affinity and thereby molecular weight.\n\nMonodisperse PEG products are used as linkers or [[molecular tether]]s to join molecular entities (as in Cipriano and Dunn<ref>Cipriano DJ, Dunn SD. \"Tethering polypeptides through bifunctional PEG cross-linking agents to probe protein function: Application to ATP synthase.\"  Proteins. 2008 Apr 28. {{PMID|18442134}}</ref>). They are also coupled to substances to make use of the [[hydrophilic]] property of PEG to enhance water [[solubility]], or to facilitate penetration of a coupled substance through cell membranes <ref>Berna M, Dalzoppo D, Pasut G, Manunta M, Izzo L, Jones AT, Duncan R, Veronese FM. \"Novel monodisperse PEG-dendrons as new tools for targeted drug delivery: synthesis, characterization and cellular uptake.\" Biomacromolecules. 2006 7:146-53\n{{PMID|16398509}}</ref> as well as to reduce [[immunogenicity]] of proteins used as therapeutic agents.\n\nThe major shareholders in the company are Erik Agner, co-founder and CEO of the Company, and Gamma Group AS.\n\n==References==\n{{reflist}}\n\n[[Category:Manufacturing companies based in Oslo]]\n", "text_old": "{{Infobox company\n | name             = Polypure AS.\n | logo             = File:Polypure logo.png\n | type             = [[Private company|Privately held]] \n | genre            = \n | foundation       = 1999\n | founder          = \n | location_city    = [[Oslo]]\n | location_country = [[Norway]]\n | location         = \n | locations        = \n | area_served      = Global\n | key_people       = [[Erik Agner]]<small> ([[Chief Executive Officer|CEO]])</small>\n | industry         = [[Pharmaceutical]]\n | products         =  [[Fine chemicals]]\n | services         = \n | revenue          = \n | operating_income = \n | net_income       = \n | owner            = \n | num_employees    = \n | parent           = \n | divisions        = \n | subsid           = \n | slogan           = \n | homepage         = [http://www.polypure.no polypure.no]\n | footnotes        = \n | intl             =\n}}\n\n'''Polypure''' is a [[Norway|Norwegian]] company that manufactures and markets monodisperse PEG (poly[[ethylene glycol]]) derivatives for applications in [[nanotechnology]], [[biotechnology]] and in [[pharmaceutical sciences]]. \n\nIts headquarters are located in the [[Oslo Innovation Center]],<ref>[http://www.forskningsparken.no/ Hovedside - Forskningsparken<!-- Bot generated title -->]</ref> [[Oslo]], [[Norway]]. The company has been in operation since 1999.\n\nThe compounds are produced using a proprietary purification technology called Sample [[Displacement Chromatography]] (SDC).<ref>US Patent number: 6245238</ref> The technique exploits the [[correlation]] between [[molecular weight]] and binding strength of PEG species. That is, individual PEG molecules bind to the matrix within a [[chromatography]] column at differing [[Chemical affinity|affinity]] depending on their molecular weight. Because of this property, when PEG is applied to the top of a chromatography column, strong binding species take possession of the first binding positions available and thereby force weaker binders to follow the liquid flow down the column to the next vacant positions. This results in the spatial separation of PEG species within the column according to affinity and thereby molecular weight.\n\nMonodisperse PEG products are used as linkers or [[molecular tether]]s to join molecular entities (as in Cipriano and Dunn<ref>Cipriano DJ, Dunn SD. \"Tethering polypeptides through bifunctional PEG cross-linking agents to probe protein function: Application to ATP synthase.\"  Proteins. 2008 Apr 28. {{PMID|18442134}}</ref>). They are also coupled to substances to make use of the [[hydrophilic]] property of PEG to enhance water [[solubility]], or to facilitate penetration of a coupled substance through cell membranes <ref>Berna M, Dalzoppo D, Pasut G, Manunta M, Izzo L, Jones AT, Duncan R, Veronese FM. \"Novel monodisperse PEG-dendrons as new tools for targeted drug delivery: synthesis, characterization and cellular uptake.\" Biomacromolecules. 2006 7:146-53\n{{PMID|16398509}}</ref> as well as to reduce [[immunogenicity]] of proteins used as therapeutic agents.\n\nThe major shareholders in the company are Erik Agner, co-founder and CEO of the Company, and Gamma Group AS.\n\n==References==\n{{reflist}}\n\n[[Category:Manufacturing companies based in Oslo]]\n", "name_user": "Benstown", "label": "safe", "comment": "svg logo", "url_page": "//en.wikipedia.org/wiki/Polypure"}
